首页> 外文期刊>Clinical nuclear medicine >Quality and Safety in Health Care, Part XLIV Cardiac Resynchronization Therapy and Subcutaneous Defibrillator Implantable Devices
【24h】

Quality and Safety in Health Care, Part XLIV Cardiac Resynchronization Therapy and Subcutaneous Defibrillator Implantable Devices

机译:保健质量和安全,部分XLIV心脏再同步治疗和皮下除颤器可植入装置

获取原文
获取原文并翻译 | 示例
           

摘要

This article discusses 2 specialized implantable cardioverter defibrillator (ICD) devices. A special type of implantable device is available for cardiac resynchronization therapy, which can also have a defibrillator, in which case it is called a CRT-D device. In patients who meet guidelines for eligibility, a CRT-D will diminish the number of significant cardiac events including death. A subcutaneous ICD device does not need any leads placed in the vascular system and therefore does not have some of the complications that may be seen with transvenous ICDs. Also, there are patients who are not candidates for a typical ICD implantation. On the other hand, there are important disadvantages to the subcutaneous ICD.
机译:本文讨论了2种专用植入式心脏除颤器(ICD)器件。 一种特殊类型的可植入装置可用于心脏再同步治疗,其也可以具有除颤器,在这种情况下,它被称为CRT-D器件。 在符合资格准则的患者中,CRT-D将减少包括死亡在内的重要心脏事件的数量。 皮下ICD装置不需要放置在血管系统中的任何导线,因此没有用吞气ICDS看到的一些并发症。 此外,还有患者没有候选典型的ICD植入。 另一方面,皮下ICD存在重要的缺点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号